Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 04/17/2026 | CALL | $40.00 | 0 | 0 | |
| 04/17/2026 | CALL | $45.00 | 0 | 0 | |
| 04/17/2026 | CALL | $50.00 | 0 | 0 | |
| 04/17/2026 | CALL | $55.00 | 0 | 0 | |
| 04/17/2026 | CALL | $60.00 | 0 | 0 | |
| 04/17/2026 | CALL | $65.00 | 0 | 0 | |
| 01/21/2028 | PUT | $80.00 | 0 | 0 | |
| 01/21/2028 | PUT | $85.00 | 0 | 0 | |
| 01/21/2028 | PUT | $90.00 | 0 | 0 | |
| 01/21/2028 | PUT | $95.00 | 0 | 0 | |
| 01/21/2028 | PUT | $100.00 | 0 | 0 | |
| 01/21/2028 | PUT | $105.00 | 0 | 0 |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 4.75% | 3.36M | 37.7M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.88% | 2.04M | 22.91M |
| Vanguard Total Stock Market Index Fund | 2.85% | 2.01M | 22.6M |
| Price (T.Rowe) Health Sciences Fund | 2.49% | 1.76M | 19.77M |
| Federated Hermes Kaufmann Fund | 1.72% | 1.22M | 13.64M |
| iShares Russell 2000 ETF | 1.66% | 1.18M | 13.22M |
| Fidelity Growth Company Fund | 1.66% | 1.17M | 13.15M |
| Federated Hermes Kaufmann Small Cap Fund | 1.57% | 1.11M | 12.47M |
| Vanguard Extended Market Index Fund | 1.27% | 899.79k | 10.1M |
| Artisan International Small-Mid Fund | 1.15% | 811.71k | 9.11M |
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--TBHC, RNA, NEW, and TWO
01/30 11:46 pm
Benzinga
Read moreNovartis Projects Faster Growth Through 2030 After Raising Drug Forecasts
11/20 01:43 pm
Benzinga
Read moreNovartis Maintains Outlook Even As Generics Bite Into Profits
10/28 06:58 am
Benzinga
Read moreWhy Dyne Therapeutics Stock Crushed the Market on Monday
10/27 06:17 pm
The Motley Fool
Read moreStock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus
10/27 06:02 am
Benzinga
Read moreNovartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline
10/26 01:00 pm
GlobeNewswire Inc.
Read moreTop Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
07/01 01:38 pm
Benzinga
Read moreAvidity (RNA) Up 33% on Rare Muscle Disease Study Results
06/13 10:39 am
Zacks Investment Research
Read moreA Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
06/10 08:01 am
Benzinga
Read more2 Potentially High-Reward Growth Stocks to Buy Right Now
05/29 08:45 am
The Motley Fool
Read moreCoherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
05/09 05:15 pm
Zacks Investment Research
Read moreAbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
05/07 06:05 pm
Zacks Investment Research
Read moreTo The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
04/18 02:29 pm
Benzinga
Read moreWhere Avidity Biosciences Stands With Analysts
04/11 08:00 am
Benzinga
Read moreNeuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
03/14 03:29 pm
Benzinga
Read moreAmerican Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
03/05 10:30 am
Benzinga
Read moreA Closer Look at 5 Analyst Recommendations For Avidity Biosciences
03/05 08:00 am
Benzinga
Read moreTesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
03/04 11:40 am
Benzinga
Read moreHormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
02/29 12:30 pm
Benzinga
Read moreTop 3 Health Care Stocks You May Want To Dump In Q1
02/29 11:40 am
Benzinga
Read moreTech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge
02/29 10:20 am
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
02/28 06:20 pm
Zacks Investment Research
Read moreStrength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?
02/07 05:13 am
Zacks Investment Research
Read moreStrength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
01/29 09:54 am
Zacks Investment Research
Read moreThe Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks
01/06 06:58 am
MarketWatch
Read moreBristol Myers (BMY) Partners With SystImmune for Oncology Drug
12/12 12:04 pm
Zacks Investment Research
Read moreWill Bristol Myers' (BMY) Efforts to Boost Portfolio be Enough?
12/08 01:21 pm
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
12/01 06:09 am
Zacks Investment Research
Read moreBiotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
11/30 11:33 am
Zacks Investment Research
Read moreCompany News for Nov 29, 2023
11/29 10:35 am
Zacks Investment Research
Read moreDow refreshes highest close in nearly four months after Fed official’s remarks, with inflation data ahead
11/28 05:56 pm
MarketWatch
Read morePDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday
11/28 10:39 am
Benzinga
Read moreUS Stocks Mixed; House Prices Rise In September
11/28 10:33 am
Benzinga
Read moreAvidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments
11/28 09:33 am
MarketWatch
Read moreWhere Avidity Biosciences Stands With Analysts
08/09 08:00 am
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
08/08 07:15 pm
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
05/22 11:00 am
Benzinga
Read moreWhat 10 Analyst Ratings Have To Say About Avidity Biosciences
05/17 05:00 pm
Benzinga
Read moreAvidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
05/09 06:15 pm
Zacks Investment Research
Read more